R&D
Envisioning a World Without Disease
In June, pharmaphorum came together with the Connected World Without …
19796 items found
News
FDA will add digital health advisory committee to its roster
The FDA is setting up a new advisory committee to provide independent …
Digital
How big pharma cares for its own
Pharma companies have a mission to help their customers stay healthy. …
Oncology
Partner Content
R&D
Partner Content
7th Obesity & NASH Drug Development Summit
Reuniting metabolic experts to enable the assessment of the …
News
Faron’s Clever-1 drug shows promise in blood cancers
Faron Pharmaceuticals has reported data from a phase 1/2 trial …
News
Novo Nordisk’s semaglutide aces another outcomes trial
Novo Nordisk has halted a phase 3 trial of its Ozempic formulation of …
News
Eversana acquires pharmaphorum owner Healthware Group
Eversana has acquired pharmaphorum parent Healthware Group in a move …
R&D
Partner Content
Antifibrotic Drug Development Summit
As fibrosis stakeholders invest in bolstering their early pipeline to …
Digital
From the editor-in-chief: On Eversana’s acquisition of Healthware Group
As you may have read already, Healthware Group, the parent company of …
News
Sanofi partners BioMap on AI hunt for biologic therapies
Sanofi has added another dimension to the use of artificial …
Digital
Economist Impact’s Future of Health Europe Summit: Day One
Centred on its main themes of sustainability, inclusivity, and …
Sales & Marketing
Four key strategies for optimising your medical congress str...
Field medical education before launch is linked to greater launch success, improving treatment adoption by up to 50%.
Digital
Sponsored
The AI effect in pharma commercial strategy: From data to re...
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
From neurosurgery to focused ultrasound: Not if, but when
Therapeutic or focused ultrasound began being applied to neurologic conditions less than a decade ago, but its potential in a wide spectrum of brain applications is high.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
EHS&S for Biopharma & Pharma Summit
Implementing Corporate & Regulatory-Guided EHS Practices to Achieve Zero Biosafety, Ergonomic & Chemical Incidents for Employee Safety Across Global Facilities
R&D
Partner Content
Proteomic Based Drug Discovery Summit 2025
Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
